The Biodefence Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increasing R&D Investments in Developed Countries
Growing R&D investments enable pharmaceutical and biopharmaceutical companies to manufacture superior quality and technologically advanced bio-threat detection devices that should significantly impact the industry growth. Furthermore, European government also supports the R&D activities to manufacture vaccines against various diseases such as anthrax, small pox and botulism in large batches to fight infections and prevent the spread of endemic diseases. Bioterrorism attacks lead to deaths and may weaken the economy hence, government funds various pharmaceutical as well as biopharmaceutical companies that will elevate the industry growth in foreseeable future.
Increasing Awareness Regarding Bioterrorism Attacks to Propel Industry Growth
Increasing awareness regarding bioterrorism attacks in developed as well as underdeveloped economies will significantly fuel the biodefence market growth over the forecast period. Owing to the advent of internet and growing adoption of social media, news about the biological warfare in any part of the world can spread across the globe. It can cause anxiety to people located faraway and can greatly impact trade and travel. Governments in the developing countries such as Japan and India plan public awareness campaigns to raise public awareness about bioterrorism attacks. Such preventive measures undertaken by the government to combat various endemic diseases will boost industry growth in the foreseeable future.
Low Government Funding in Underdeveloped Regions Likely to Challenge Market Growth
Minimal government intervention and low R&D funding in underdeveloped regions will impede the biodefence market growth over the forecast period. Furthermore, due to poor economic development, governments and regulatory authorities in countries such as Mexico and Brazil are unable to make significant investments to promote the use of biothreat detection devices. There is a lack of awareness in developing regions about the availability of technologically advanced biothreat detection devices. Additionally, there is no established regulatory framework for biodefence devices and vaccines in underdeveloped economies. Key players that operate in the biodefence industry find it difficult to enter these countries due to changing trade policies. As a result, the distribution of tools and vaccinations used to combat bioterrorism is low in emerging regions which may hamper the Biodefence market growth.
What Questions Should You Ask before Buying a Market Research Report?
• How is the Biodefence Market evolving?
• What is driving and restraining the Biodefence Market?
• How will each Biodefence submarket grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each Biodefence submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading Biodefence Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Biodefence development projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of Biodefence development projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the Biodefence Market?
• Where is the Biodefence Market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Biodefence Market today, and over the next 10 years:
• Our 197-page report provides 112 tables and 107 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Biodefence Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising prices of bio-threat detection devices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
By Product
• Vaccines
– Anthrax
– Small Pox
– Botulism
– Others
• Biothreat detection devices
– Assays and reagents
– Detectors
– Identifiers
– Samplers
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Biodefence Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Alexeter Technologies, LLC,
• Altimmune
• Achaogen, Inc.
• Alnylam Pharmaceuticals
• ANP Technology
• Bavarian Nordic
• BBI Detection
• Biofire Defense (bioMerieux SA)
• Biosearch Technologies
• Bruker
• Dynport Vaccine Company
• Electronic Sensor Technology Inc.
• Elusys Therapeutics
• Emergent BioSolutions Inc.
• Ichor Medical
• NanoLogix
• New Horizons Diagnostic Corporation
• PositiveID Corporation
• Research International
• SIGA Technologies, Inc.
• Statera Biopharma (Cleveland Biolabs)
• Smith’s Detection
• Synexis Systems
Overall world revenue for Biodefence Market, 2023 to 2033 in terms of value the market will surpass US$15,922 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Biodefence Market, 2023 to 2033 report help you?
In summary, our 197-page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Biodefence Market, 2023 to 2033 Market, with forecasts for Type of Product, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 16 key national markets – See forecasts for the Biodefence Market, 2023 to 2033 market in North America, Europe, Asia-Pacific and Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles of the major companies involved in the Biodefence Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Biodefence Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Biodefence Market Report 2023-2033: Forecasts by Product (Vaccines (Anthrax, Smallpox, Botulism), Biothreat Detection Devices (Assays and Reagents, Detectors, Identifiers, Samplers)) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Biodefence Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing R&D investments by the government
3.2.1.2 Favourable government initiatives in emerging economies
3.2.1.3 Technological developments in biotechnology sector in the developed countries
3.2.2 Market Restraining Factors
3.2.2.1 Low R&D funding in underdeveloped regions
3.2.3 Market Opportunities
3.2.3.1 Increasing list of bio-threat agents
3.2.3.2 Development of advanced biotechnology products
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Biodefence Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Biodefence Market Size Estimation and Forecast by Product
4.4 Vaccines
4.4.1 Anthrax
4.4.1.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.1.2 Market Share by Region, 2023 & 2033 (%)
4.4.2 Small Pox
4.4.2.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.2.2 Market Share by Region, 2023 & 2033 (%)
4.4.3 Botulism
4.4.3.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.3.2 Market Share by Region, 2023 & 2033 (%)
4.4.4 Others
4.4.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Biothreat detection devices
4.5.1 Assays and reagents
4.5.1.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.1.2 Market Share by Region, 2023 & 2033 (%)
4.5.2 Detectors
4.5.2.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.2.2 Market Share by Region, 2023 & 2033 (%)
4.5.3 Identifiers
4.5.3.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.3.2 Market Share by Region, 2023 & 2033 (%)
4.5.4 Samplers
4.5.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.4.2 Market Share by Region, 2023 & 2033 (%)
5 Biodefence Market Analysis by Region
5.1 Key Findings
5.2 Regional Segment: Market Attractiveness Index
5.3 Biodefence Market Size Estimation and Forecast
6 North America Biodefence Market Analysis
6.1 Key Findings
6.2 North America Biodefence Market Attractiveness Index
6.3 North America Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
6.4 North America Biodefence Market Size Estimation and Forecast by Country
6.5 North America Biodefence Market Size Estimation and Forecast by Product
6.6 U.S. Biodefence Market Analysis
6.7 Canada Biodefence Market Analysis
7 Europe Biodefence Market Analysis
7.1 Key Findings
7.2 Europe Biodefence Market Attractiveness Index
7.3 Europe Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
7.4 Europe Biodefence Market Size Estimation and Forecast by Country
7.5 Europe Biodefence Market Size Estimation and Forecast by Product
7.6 Germany Biodefence Market Analysis
7.7 France Biodefence Market Analysis
7.8 UK Biodefence Market Analysis
7.9 Italy Biodefence Market Analysis
7.10 Spain Biodefence Market Analysis
7.11 Russia Biodefence Market Analysis
7.12 Rest of Europe Biodefence Market Analysis
8 Asia Pacific Biodefence Market Analysis
8.1 Key Findings
8.2 Asia Pacific Biodefence Market Attractiveness Index
8.3 Asia Pacific Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
8.4 Asia Pacific Biodefence Market Size Estimation and Forecast by Country
8.5 Asia Pacific Biodefence Market Size Estimation and Forecast by Product
8.6 Japan Biodefence Market Analysis
8.7 China Biodefence Market Analysis
8.8 India Biodefence Market Analysis
8.9 Australia Biodefence Market Analysis
8.10 South Korea Biodefence Market Analysis
8.11 Rest of Asia Pacific Biodefence Market Analysis
9 Latin America Biodefence Market Analysis
9.1 Key Findings
9.2 Latin America Biodefence Market Attractiveness Index
9.3 Latin America Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
9.4 Latin America Biodefence Market Size Estimation and Forecast by Country
9.5 Latin America Biodefence Market Size Estimation and Forecast by Product
9.6 Brazil Biodefence Market Analysis
9.7 Mexico Biodefence Market Analysis
9.8 Rest of Latin America Biodefence Market Analysis
10 MEA Biodefence Market Analysis
10.1 Key Findings
10.2 MEA Biodefence Market Attractiveness Index
10.3 MEA Biodefence Market by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 MEA Biodefence Market Size Estimation and Forecast by Country
10.5 MEA Biodefence Market Size Estimation and Forecast by Product
10.6 GCC Biodefence Market Analysis
10.7 South Africa Biodefence Market Analysis
10.8 Rest of MEA Biodefence Market Analysis
11 Company Profiles
11.1 Competitive Landscape, 2021
11.1.1 BioFire Defense
11.1.2 Bruker Corporation
11.1.3 Emergent BioSolutions
11.1.4 Smiths detection
11.2 Alexeter Technologies, LLC,
11.2.1 Company Snapshot
11.2.2 Company Overview
11.2.3 Product Benchmarking
11.3 Altimmune
11.3.1 Company Snapshot
11.3.2 Company Overview
11.3.3 Financial Analysis
11.3.3.1 Net Revenue, 2017-2021
11.3.3.2 R&D, 2017-2021
11.3.4 Product Benchmarking
11.4 ANP Technology
11.4.1 Company Snapshot
11.4.2 Company Overview
11.4.3 Product Benchmarking
11.5 Bavarian Nordic
11.5.1 Company Snapshot
11.5.2 Company Overview
11.5.3 Financial Analysis
11.5.3.1 Net Revenue, 2017-2021
11.5.3.2 R&D, 2017-2021
11.5.3.3 Regional Market Shares, 2021
11.5.4 Product Benchmarking
11.5.5 Strategic Outlook
11.6 Biofire Defense (bioMerieux SA)
11.6.1 Company Snapshot
11.6.2 Company Overview
11.6.3 Financial Analysis
11.6.3.1 Net Revenue, 2017-2021
11.6.3.2 R&D, 2017-2021
11.6.3.3 Regional Market Shares, 2021
11.6.4 Product Benchmarking
11.6.5 Strategic Outlook
11.7 Biosearch Technologies
11.7.1 Company Snapshot
11.7.2 Company Overview
11.7.3 Financial Analysis
11.7.3.1 Net Revenue, 2017-2021
11.7.3.2 Regional Market Shares, 2021
11.7.4 Product Benchmarking
11.8 Bruker
11.8.1 Company Snapshot
11.8.2 Company Overview
11.8.3 Financial Analysis
11.8.3.1 Net Revenue, 2017-2021
11.8.3.2 R&D, 2017-2021
11.8.3.3 Regional Market Shares, 2021
11.8.4 Product Benchmarking
11.9 Electronic Sensor Technology Inc.
11.9.1 Company Snapshot
11.9.2 Company Overview
11.9.3 Product Benchmarking
11.10 Elusys Therapeutics
11.10.1 Company Snapshot
11.10.2 Company Overview
11.10.3 Product Benchmarking
11.10.4 Strategic Outlook
11.11 Emergent BioSolutions Inc.
11.11.1 Company Snapshot
11.11.2 Company Overview
11.11.3 Financial Analysis
11.11.3.1 Net Revenue, 2017-2021
11.11.3.2 R&D, 2017-2021
11.11.4 Product Benchmarking
11.11.5 Strategic Outlook
11.12 Ichor Medical
11.12.1 Company Snapshot
11.12.2 Company Overview
11.12.3 Product Benchmarking
11.13 NanoLogix
11.13.1 Company Snapshot
11.13.2 Company Overview
11.13.3 Product Benchmarking
11.14 New Horizons Diagnostic Corporation
11.14.1 Company Snapshot
11.14.2 Company Overview
11.14.3 Product Benchmarking
11.14.4 Strategic Outlook
11.15 PositiveID Corporation
11.15.1 Company Snapshot
11.15.2 Company Overview
11.15.3 Product Benchmarking
11.16 SIGA Technologies, Inc
11.16.1 Company Snapshot
11.16.2 Company Overview
11.16.3 Financial Analysis
11.16.3.1 Net Revenue, 2017-2021
11.16.3.2 R&D, 2017-2021
11.16.4 Product Benchmarking
11.16.5 Strategic Outlook
11.17 Alnylam Pharmaceuticals
11.17.1 Company Snapshot
11.17.2 Company Overview
11.17.3 Financial Analysis
11.17.3.1 Net Revenue, 2017-2021
11.17.3.2 R&D, 2017-2021
11.17.4 Product Benchmarking
11.17.5 Strategic Outlook
11.18 BBI Detection
11.18.1 Company Snapshot
11.18.2 Company Overview
11.18.3 Product Benchmarking
11.19 Statera Biopharma
11.19.1 Company Snapshot
11.19.2 Company Overview
11.19.3 Financial Analysis
11.19.3.1 Net Revenue, 2017-2021
11.19.3.2 R&D, 2017-2021
11.19.4 Product Benchmarking
11.20 Dynport Vaccine Company
11.20.1 Company Snapshot
11.20.2 Company Overview
11.20.3 Product Benchmarking
11.21 Research International
11.21.1 Company Snapshot
11.21.2 Company Overview
11.21.3 Product Benchmarking
11.22 Smith’s Detection
11.22.1 Company Snapshot
11.22.2 Company Overview
11.22.3 Product Benchmarking
11.22.4 Strategic Outlook
11.23 Synexis Systems
11.23.1 Company Snapshot
11.23.2 Company Overview
11.23.3 Product Benchmarking
11.23.4 Strategic Outlook
12 Conclusion and Recommendations
12.1 Concluding Remarks from Visiongain
12.2 Recommendations for Market Players
List of Tables
Table 1 Biodefence Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 3 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 4 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 5 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 6 Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 7 Biodefence Devices Market by Vaccines, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 8 Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 9 Biodefence Market Forecast by Product, 2023-2033 (US$ million)
Table 10 Anthrax Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 11 Small Pox Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 12 Botulism Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 13 Others Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 14 Assays and reagents Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 15 Detectors Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 16 Identifiers Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 17 Samplers Market Forecast by Region, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 18 Biodefence Market Forecast by Region, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 19 North America Biodefence Market Forecast by Country
Table 20 North America Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 21 North America Biodefence Devices Market by Vaccines, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 22 North America Biodefence Devices Market by Biothreat detection devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 23 U.S. Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 24 Canada Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 25 Europe Biodefence Market Forecast by Country, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 26 Europe Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 27 Europe Biodefence Devices Market by Vaccines, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 28 Europe Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 29 Germany Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 30 France Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 31 UK Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 32 Italy Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 33 Spain Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 34 Russia Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 35 Rest of Europe Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 36 Asia Pacific Biodefence Market Forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 37 Asia Pacific Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 38 Asia Pacific Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 39 Asia Pacific Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR(%))
Table 40 Japan Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 41 China Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 42 India Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 43 Australia Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 44 South Korea Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 45 Rest of Asia Pacific Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 46 Latin America Biodefence forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 47 Latin America Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 48 Latin America Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 49 Latin America Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 50 Brazil Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 51 Mexico Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 52 Rest of Latin America Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 53 MEA Biodefence forecast by Country 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 54 MEA Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 55 MEA Biodefence Devices Market by Product, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 56 MEA Biodefence Devices Market by Biothreat Detection Devices, 2023-2033 (US$ Mn, AGR (%), CAGR (%))
Table 57 GCC Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 58 South Africa Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 59 Rest of MEA Biodefence Market Forecast, 2023-2033 (US$ Mn, AGR %, CAGR %)
Table 60 Alexeter Technologies, LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 61 Alexeter Technologies, LLC: Product Benchmarking
Table 62 Altimmune: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 Altimmune: Product Benchmarking
Table 64 ANP Technology: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 65 ANP Technology: Product Benchmarking
Table 66 Bavarian Nordic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 67 Bavarian Nordic: Product Benchmarking
Table 68 Bavarian Nordic: Strategic Outlook
Table 69 Biofire Defense (bioMerieux SA): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 70 Biofire Defense (bioMerieux SA): Product Benchmarking
Table 71 Biofire Defense (bioMerieux SA.: Strategic Outlook
Table 72 Biosearch Technologies : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 73 Biosearch Technologies: Product Benchmarking
Table 74 Bruker: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 Bruker: Product Benchmarking
Table 76 Electronic Sensor Technology Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Electronic Sensor Technology Inc .: Product Benchmarking
Table 78 Elusys Therapeutics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Elusys Therapeutics .: Product Benchmarking
Table 80 Elusys Therapeutics : Strategic Outlook
Table 81 Emergent BioSolutions Inc.: (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Emergent BioSolutions Inc.: Product Benchmarking
Table 83 Emergent BioSolutions Inc.: Strategic Outlook
Table 84 Ichor Medical: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Ichor Medical: Product Benchmarking
Table 86 NanoLogix: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 NanoLogix: Product Benchmarking
Table 88 New Horizons Diagnostic Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 New Horizons Diagnostic Corporation: Product Benchmarking
Table 90 New Horizons Diagnostic Corporation: Strategic Outlook
Table 91 PositiveID Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 PositiveID Corporation .: Product Benchmarking
Table 93 SIGA Technologies, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 SIGA Technologies, Inc.: Product Benchmarking
Table 95 SIGA Technologies, Inc: Strategic Outlook
Table 96 Alnylam Pharmaceuticals: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Alnylam Pharmaceuticals: Product Benchmarking
Table 98 Alnylam Pharmaceuticals: Strategic Outlook
Table 99 BBI Detection: Key Details, (CEO, HQ, Founded, No. of Employees, Business Segment)
Table 100 BBI Detection: Product Benchmarking
Table 101 Statera Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Statera Biopharma: Product Benchmarking
Table 103 Dynport Vaccine Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Dynport Vaccine Company: Product Benchmarking
Table 105 Research International: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Research International: Product Benchmarking
Table 107 Smith’s Detection: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Smith’s Detection : Product Benchmarking
Table 109 Smith’s Detection: Strategic Outlook
Table 110 Synexis Systems: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Synexis Systems: Product Benchmarking
Table 112 Synexis Systems: Strategic Outlook
List of Figures
Figure 1 Biodefence Market Segmentation
Figure 2 Biodefence Market by Product: Market Attractiveness Index
Figure 3 Biodefence Market by Vaccines: Market Attractiveness Index
Figure 4 Biodefence Market by Product: Market Attractiveness Index
Figure 5 Biodefence Market Attractiveness Index by Region
Figure 6 Biodefence Market: Market Dynamics
Figure 7 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 8 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 9 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 10 Biodefence Market by Region, 2023-2033 (US$ Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 11 Biodefence Market: Porter’s Five Forces Analysis
Figure 12 Biodefence Market: PEST Analysis
Figure 13 Biodefence Market by Product: Market Attractiveness Index
Figure 14 Biodefence Market by Vaccines: Market Attractiveness Index
Figure 15 Biodefence Market by Product: Market Attractiveness Index
Figure 16 Biodefence Market Share Forecast by Product, 2023-2033 (%)
Figure 17 Anthrax Market Forecast by Region, 2023-2033 (US$ million)
Figure 18 Anthrax Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Small Pox Market Forecast by Region, 2023-2033 (US$ million)
Figure 20 Small Pox Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Botulism Market Forecast by Region, 2023-2033 (US$ million)
Figure 22 Botulism Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 24 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 25 Assays and reagents Market Forecast by Region, 2023-2033 (US$ million)
Figure 26 Assays and reagents Market Share Forecast by Region, 2023 & 2033 (%)
Figure 27 Detectors Market Forecast by Region, 2023-2033 (US$ million)
Figure 28 Detectors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 29 Identifiers Market Forecast by Region, 2023-2033 (US$ million)
Figure 30 Identifiers Market Share Forecast by Region, 2023 & 2033 (%)
Figure 31 Samplers Market Forecast by Region, 2023-2033 (US$ million)
Figure 32 Samplers Market Share Forecast by Region, 2023 & 2033 (%)
Figure 33 Biodefence Market by Region: Market Attractiveness Index
Figure 34 Biodefence Market by Region, 2023-2033 (US$ Mn)
Figure 35 Biodefence Market Share Forecast by Region 2023, 2033(%)
Figure 36 North America Biodefence Market Attractiveness Index
Figure 37 North America Biodefence Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 38 North America Biodefence Market Forecast by Country, 2023-2033 (US$ million)
Figure 39 North America Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
Figure 40 North America Biodefence Market Forecast by Product, 2023-2033 (US$ million)
Figure 41 North America Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
Figure 42 U.S. Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 43 Canada Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 44 Europe Biodefence Market Attractiveness Index
Figure 45 Europe Biodefence Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 46 Europe Biodefence Market Forecast by Country, 2023-2033 (US$ million)
Figure 47 Europe Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
Figure 48 Europe Biodefence Market Forecast by Product, 2023-2033 (US$ million)
Figure 49 Europe Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
Figure 50 Germany Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 51 France Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 52 UK Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 53 Italy Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 54 Spain Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 55 Russia Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 56 Rest of Europe Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 57 Asia Pacific Biodefence Market Attractiveness Index
Figure 58 Asia Pacific Biodefence Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 59 Asia Pacific Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 60 Asia Pacific Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
Figure 61 Asia Pacific Biodefence Market Forecast by Product, 2023-2033 (US$ million, AGR %)
Figure 62 Asia Pacific Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
Figure 63 Japan Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 64 China Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 65 India Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 66 Australia Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 67 South Korea Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 68 Rest of Asia Pacific Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 69 Latin America Biodefence Market Attractiveness Index
Figure 70 Latin America Biodefence Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 71 Latin America Biodefence Market Forecast by Country, 2023-2033 (US$ million)
Figure 72 Latin America Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
Figure 73 Latin America Biodefence Market Forecast by Product, 2023-2033 (US$ million)
Figure 74 Latin America Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
Figure 75 Brazil Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 76 Mexico Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 77 Rest of Latin America Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 78 MEA Biodefence Market Attractiveness Index
Figure 79 MEA Biodefence Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 80 MEA Biodefence Market Forecast by Country, 2023-2033 (US$ million)
Figure 81 MEA Biodefence Market Share Forecast by Country, 2023 & 2033 (%)
Figure 82 MEA Biodefence Market Forecast by Product, 2023-2033 (US$ million)
Figure 83 MEA Biodefence Market Share Forecast by Product, 2023 & 2033 (%)
Figure 84 GCC Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 85 South Africa Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 86 Rest of MEA Biodefence Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 87 Altimmune: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 88 Altimmune: R&D, 2017-2021 (US$ million, AGR%)
Figure 89 Bavarian Nordic: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 90 Bavarian Nordic: R&D, 2017-2021 (US$ million, AGR%)
Figure 91 Bavarian Nordic: Regional Market Shares, 2021
Figure 92 Biofire Defense (bioMerieux SA): Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 93 Biofire Defense (bioMerieux SA): R&D, 2017-2021 (US$ million, AGR%)
Figure 94 Biofire Defense (bioMerieux SA): Regional Market Shares, 2021
Figure 95 Biosearch Technologies: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 96 Biosearch Technologies.: Regional Market Shares, 2021
Figure 97 Bruker: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 98 Bruker: R&D, 2017-2021 (US$ million, AGR%)
Figure 99 Bruker: Regional Market Shares, 2021
Figure 100 Emergent BioSolutions Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 101 Emergent BioSolutions Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 102 SIGA Technologies, Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 103 SIGA Technologies, Inc.: R&D, 2017-2021 (US$ million, AGR%)
Figure 104 Alnylam Pharmaceuticals: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 105 Alnylam Pharmaceuticals: R&D, 2017-2021 (US$ million, AGR%)
Figure 106 Statera Biopharma: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 107 Statera Biopharma : R&D, 2017-2021 (US$ million, AGR%)
List of Companies Profiled in the Report
Alexeter Technologies, LLC,
Altimmune
Achaogen, Inc.
Alnylam Pharmaceuticals
ANP Technology
Bavarian Nordic
BBI Detection
Biofire Defense (bioMerieux SA)
Biosearch Technologies
Bruker
Dynport Vaccine Company
Electronic Sensor Technology Inc.
Elusys Therapeutics
Emergent BioSolutions Inc.
Ichor Medical
NanoLogix
New Horizons Diagnostic Corporation
PositiveID Corporation
Research International
SIGA Technologies, Inc.
Statera Biopharma (Cleveland Biolabs)
Smith’s Detection
Synexis Systems
List of Other Companies Mentioned in the Report
AbCellera
AstraZeneca
Banbury Labels
Canopy Biosciences, LLC
Chimerix, Inc.
Coeptis Therapeutics, Inc
Cytocom
Dynavax Technologies Corporation
Encepur
Ensensor
Fulgent Pharma
Heat Biologics, Inc.
Kromek
Medison Pharma
MOLECUBES NV,
Neurescence Inc.
Novartis
Optimal Industrial Automation and Technologies
PeptiDream
PharmAthene
Prolab Instruments GmbH
RAVE LLC
Regeneron
Stratus
Valneva SE
Vaxart, Inc.
List of Associations Mentioned in the Report
American Biological Safety Association
American Society for Microbiology
Arms Control Association
Asia-Pacific Biosafety Association (APBA)
Biomedical Advanced Research and Development Authority (BARDA)
Biorisk Management Association of Kenya (BMAK)
Biosafety and Biosecurity Association of South Sudan (BBASS)
Canadian Association for Biological Safety
European Agency for the Evaluation of Medicinal Products
European Corporate Security Association (ECSA)
Georgian Biosafety Association (GeBSA)
German Biosecurity Programme
Infectious Disease Society of America
Korean Biological Safety Association
Malaysian Biosafety & Biosecurity Association
Mali Association for Biosafety & Biosecurity
Mexican Biosafety Association (AMEXBIO)
National Biosafety Association (ANBio)
National Institute of Allergy and Infectious Diseases (NIAID)
Nigerian Biological Safety Association (NiBSA)
Office of International Health and Biodefense (IHB)
Tanzania Biological Safety Association (TaBSA)
U.S. Department of Health and Human Services
U.S. Department of Homeland Security
U.S. Government Accountability Office
The U.S. Food and Drug Administration (FDA)
World Health Organization (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
